Clinical Trials Directory

Trials / Completed

CompletedNCT06763068

Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients

BIA-measured Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
575 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study was to quantify the diagnosis of pre-surgical skeletal muscle mass in elderly gastric cancer patients and to analyse its correlation with frailty. The second aim was to investigate whether skeletal muscle mass, or sarcopenia, is associated with mobility and nutritional status, and anxiety and depression. The main questions it aims to answer are whether skeletal muscle mass is significantly associated with frailty and whether it can be used as a brief screening tool for preoperative frailty.

Conditions

Interventions

TypeNameDescription
OTHERSkeletal muscle mass and frailtyMeasurement correlation variable

Timeline

Start date
2021-03-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2025-01-08
Last updated
2025-01-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06763068. Inclusion in this directory is not an endorsement.